Search

Your search keyword '"Spencer, Lisa"' showing total 268 results

Search Constraints

Start Over You searched for: Author "Spencer, Lisa" Remove constraint Author: "Spencer, Lisa" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
268 results on '"Spencer, Lisa"'

Search Results

2. Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting

3. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

5. Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with “idiopathic” interstitial lung disease

8. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

9. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

11. Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review.

12. New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

13. New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting

16. Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease.

18. Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis.

19. Notch 2 signaling contributes to intestinal eosinophil adaptations in steady state and tissue burden following oral allergen challenge.

20. Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.

21. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases.

22. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis

23. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

29. A Retrospective Analysis of 2-Year Follow-Up of Patients with Incidental Findings of Sarcoidosis.

30. Using Diffusion of Innovation Theory to Address Health of the Homeless in Hawaii.

33. Teacher Version of the My Class Inventory-Short Form: An Accountability Tool for Elementary School Counselors

34. My Class Inventory-Short Form as an Accountability Tool for Elementary School Counselors to Measure Classroom Climate

43. Fibrostenotic eosinophilic esophagitis phenotype is defined by a proliferative gene signature.

44. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.

47. Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia

48. Determining scale and sea state from water video

Catalog

Books, media, physical & digital resources